CTRI/2020/03/023835尚未招募不适用
Evaluation of investigations suitable for the endpoint of treatment in spinal tuberculosis
Dr Tensubam Tomthin Meetei1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年3月14日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- Cured status of spinal tuberculosis following anti tuberculous treatment
研究概览
简要总结
This study is an observational follow up study to evaluate the investigations suitable for finding the endpoint of treatment of spinal tuberculosis.All diagnosed cases of spinal tuberculosis who have received treatment for at least 6 months are enrolled.primary outcome will be cured status at 18 months to be determined by routine blood tests and radiological examinations along with PET scan.Secondary outcome will be to determine the best investigation for finding the cured status.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •Age more than 18 years and less than 70 years 2) Confirmed cases of Spinal Tuberculosis 3) Patients who have received anti tubercular treatment for at least 6 months.
排除标准
- •Age less than 18 years and more than 70 years 2) Associated comorbidities like Diabetes mellitus, Hypertension.
- •Patients who underwent or undergoing surgery.
结局指标
主要结局
Cured status of spinal tuberculosis following anti tuberculous treatment
时间窗: 18 months
次要结局
- Best investigation for finding the cured status(18 months)
研究者
研究点 (1)
Loading locations...
相似试验
Enrolling By Invitation
不适用
Effectiveness Validation of CELBREA® in Symptomatic Women or With Diagnostic Doubt of Breast Pathology (DETECT-BH)Breast DiseaseBenign Breast DiseaseBreast CancerNCT05857111Jose Ignacio Sánchez255
招募中
不适用
Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast CancersOvarian CancerNCT06800612IRCCS Azienda Ospedaliero-Universitaria di Bologna100
Unknown
不适用
Evaluation of SGLT2-i Effectivness and Safety in Elderly Type 2 Diabetes PatientsType2DiabetesNCT05477017University of Milan800
已完成
不适用
An Observational Study to Evaluate the Clinical Effectiveness, Quality of Life, Safety and Tolerability of Tocilizumab (TCZ) in Patients With Rheumatoid Arthritis (RA) in Daily Clinical PracticeRheumatoid ArthritisNCT02552940Hoffmann-La Roche140
Unknown
不适用
The Effects of Dapagliflozin in Normal Clinical Practice in T2DType 2 DiabetesNCT05418946University of Milan1,400